| Dr. Phillip Frost |
Chairman of the Board, Chief Executive Officer |
86 |
$972.2K - USD |
Male |
|
| Dr. Elias Zerhouni |
President, Vice Chairman of the Board |
72 |
$956.2K - USD |
Male |
|
| Dr. Jane Hsiao |
Vice Chairman of the Board, Chief Technical Officer |
76 |
$912.2K - USD |
Female |
|
| Mr. Adam Logal |
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer |
45 |
$712.2K - USD |
Male |
|
| Dr. Charles Bishop |
Chief Executive Officer of OPKO Renal |
71 |
- |
Male |
|
| Dr. Tony Cruz |
Chief Executive Officer, Transition Therapeutics, Inc |
69 |
- |
Male |
|
| Mr. Steven Rubin |
Executive Vice President - Administration, Director |
62 |
$822.2K - USD |
Male |
|
| Dr. Gary Nabel |
Chief Innovation Officer, Director |
69 |
- |
Male |
|
| Mr. Alexis Borisy |
Independent Director |
51 |
$97.88K - USD |
Male |
|
| Dr. Richard Krasno |
Independent Director |
81 |
$111.7K - USD |
Male |
|
| Mr. Prem Lachman |
Independent Director |
62 |
$107.7K - USD |
Male |
|
| Dr. Roger Medel |
Independent Director |
76 |
$90.00K - USD |
Male |
|
| Mr. John Paganelli |
Independent Director |
88 |
$105.0K - USD |
Male |
|
| Mr. Richard Pfenniger |
Independent Director |
67 |
$174.2K - USD |
Male |
|
| Dr. Alice Yu |
Independent Director |
79 |
$82.50K - USD |
Female |
|
| Ms. Yvonne Briggs |
Investor Relations |
|
- |
Female |
|
